OTC drug/cosmetics national uniformity Senate floor debate set for July 28.
This article was originally published in The Tan Sheet
Executive Summary
OTC/COSMETICS NATIONAL UNIFORMITY BACKED BY TWO FORMER FDA COMMISSIONERS, Arthur Hull Hayes, MD, and Charles Edwards, MD, in July 23 and July 21 letters to Senate Labor & Human Resources Chairman James Jeffords (R-Vt.). Both letters emphasize that language in the OTC and cosmetics national uniformity clause of Jefford's FDA reform bill (S 830) already allows states to petition for exemption from a national standard. Edwards writes that "national uniformity should play a greater role in FDA-state relations." He points out, however, that "valid and growing state interests also must be recognized" and that S 830 accommodates these concerns.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning